WASHINGTON, D.C. - The oncology community will convene March 2 - 4, 2022, in Washington, D.C., and online, to collaborate on transformative solutions for cancer care through intimate discussions and engaging interactive educational sessions.
ACCC will host over 20 sessions in a new, streamlined agenda, focused on the day’s most pressing cancer care issues. Oncology professionals, industry supporters, and media are invited to join a limited in-person gathering or attend online for completely interactive sessions that will allow all attendees the opportunity to engage with the group in real-time.
What: ACCC 48th Annual Meeting & Cancer Center Business Summit
When: March 2 - 4, 2022
Where: Washington Hilton, DC at 1919 Connecticut Ave NW, Washington, DC 20009, and online. A link to the virtual platform to be provided upon registration. Interested attendees can register on ACCC’s website: ACCC Summit Registration. Members of the media are invited to attend and may contact lgardner@accc-cancer.org to register.
Featured Sessions:
Wednesday, March 2
Thursday, March 3
Friday, March 4
For details on sessions and speakers, visit the ACCC website.
January 21, 2026
October 30, 2025
Decentralized clinical trial approaches, including remote consent, telehealth, local laboratory and imaging services, and more, can help reduce some of the many barriers that prevent eligible patients from participating in trials. But as the participants in ACCC’s Advancing Decentralized Clinical Trials in the Community Setting Roundtable Series emphasized, implementing DCT elements is not simply a matter of adopting new technology. Doing so successfully requires thoughtful workflows and oversight structures that consider equity, scalability, and sustainability.
